Pro Medicus Limited ( (AU:PME) ) has shared an update.
Pro Medicus Limited has announced a daily update on its ongoing on-market buy-back program. As of March 31, 2025, the company has repurchased a total of 25,856 ordinary fully paid securities, with an additional 1,220 securities bought back on the previous day. This buy-back initiative reflects Pro Medicus Limited’s strategic approach to managing its capital structure and potentially enhancing shareholder value.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software solutions and services primarily for radiology departments. The company focuses on delivering innovative medical imaging products that enhance clinical workflows and improve patient outcomes.
YTD Price Performance: -16.19%
Average Trading Volume: 504
Technical Sentiment Signal: Sell
Current Market Cap: $13.29B
For a thorough assessment of PME stock, go to TipRanks’ Stock Analysis page.